AMPE
Ampio Pharmaceuticals Inc.
AMPE
AMPE
Delisted
AMPE was delisted on the 12th of April, 2024.
56 hedge funds and large institutions have $4.55M invested in Ampio Pharmaceuticals Inc. in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 18
54% less capital invested
Capital invested by funds: $9.82M → $4.55M (-$5.27M)
Holders
56
Holding in Top 10
1
Calls
$61K
Puts
$36K
Top Buyers
| 1 | +$241K | |
| 2 | +$167K | |
| 3 | +$151K | |
| 4 |
Goldman Sachs
New York
|
+$137K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$94K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$355K | |
| 3 | -$329K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$207K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$196K |